Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 106690401000001110 | Midostaurin (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 106690501000001114 | Midostaurin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Midostaurin | Is a | Substance with protein kinase inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Midostaurin 25mg capsules | Has specific active ingredient | False | Midostaurin | Inferred relationship | Existential restriction modifier | |
| Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) | Has specific active ingredient | False | Midostaurin | Inferred relationship | Existential restriction modifier | |
| Midostaurin 25mg capsules 56 capsule | Has specific active ingredient | False | Midostaurin | Inferred relationship | Existential restriction modifier | |
| Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) 56 capsule 2 x 28 capsules | Has specific active ingredient | False | Midostaurin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR